CAS
MRK icon

CTC Alternative Strategies’s Merck MRK Stock Holding History

CTC Alternative Strategies’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,320
Closed -$3.11M – 154
2025
Q2 		$3.11M Buy
+39,320
New +$3.13M 2.72% 9
2024
Q4 		– Sell
-1,976
Closed -$224K – 75
2024
Q3 		$224K Buy
+1,976
New +$235K 0.28% 46
2023
Q3 		– Sell
-2,050
Closed -$237K – 148
2023
Q2 		$237K Buy
+2,050
New +$233K 0.29% 107
2014
Q3 		– Sell
-10,375
Closed -$573K – 167
2014
Q2 		$573K Buy
+10,375
New +$566K 0.48% 44
2013
Q4 		– Sell
-11,191
Closed -$508K – 165
2013
Q3 		$508K Buy
+11,191
New +$511K 0.78% 14

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CTC Alternative Strategies's MRK Position: Q3 2025 in Review

CTC Alternative Strategies sold out of Merck (MRK) in Q3 2025, closing a stake of 39,320 shares — an estimated $3.11M sold.

CTC Alternative Strategies first reported a position in MRK in Q3 2013 and held it in 5 quarters. The position peaked at $3.11M in Q2 2025. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • CTC Alternative Strategies reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • CTC Alternative Strategies sold 39,320 Merck shares in Q3 2025, an estimated $3.11M.
  • CTC Alternative Strategies first reported a position in Merck in Q3 2013 and held it in 5 quarters.
  • CTC Alternative Strategies's Merck position peaked at $3.11M in Q2 2025.
  • 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on CTC Alternative Strategies's 13F filing for Q3 2025, filed 15 Dec 2025.